Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genentech, a member of the Roche Group, has entered into a five-year agreement with PatientsLikeMe to explore use of its global online patient network to develop new ways of researching patients’ real-world experience with disease and treatment.
Subscribe to our email newsletter
The deal, which is the first broad research collaboration between PatientsLikeMe and a pharmaceutical company, offers PatientsLikeMe the opportunity to expand its patient network in oncology.
PatientsLikeMe co-founder and chairman Jamie Heywood said the company Genentech’s leadership and commitment to this mission brings the company closer to having patients at the true center of healthcare.
"With Genentech we can now embark on a journey to bring together many stakeholders across healthcare and collaborate with patients in a new way," Heywood said.
Genentech senior vice president of Medical Affairs Bruce Cooper said the collaboration with PatientsLikeMe will allow the company to learn more from patients with serious diseases, and better integrate their insights into its decision-making.
"We hope our participation will encourage broader engagement of others involved in the delivery of healthcare and support a stronger voice for patients," Cooper said.
The deal provides Genentech the opportunity to use PatientsLikeMe’s Global Network Access, a new service for pharmaceutical companies that offers a range of data, research and tools.
The service includes access to PatientsLikeMe’s network to enable cross-sectional research and broader discovery of patient insights as well as to improved customized research services and capabilities.
It also provides access to focused research projects to assess and develop new medical evidence, measures and standards of health in addition to PatientsLikeMe’s clinical trial awareness tool, which allows patients to learn about clinical trials.